TUCSON, Ariz., April 18, 2013 /PRNewswire/ -- SynCardia Systems, Inc. (www.syncardia.com), manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that The Nebraska Medical Center in Omaha has performed the state's first implant of the SynCardia temporary Total Artificial Heart to save the life of 42-year-old Greg Rathe (photo) and bridge him to a second heart transplant.
Watch video of Greg Rathe 's story -
"Greg had chronic rejection of his donated heart," said Mike Moulton , MD, chief of cardiothoracic surgery and heart transplant surgeon at The Nebraska Medical Center. "That process affected both the left and right ventricles. Because his heart had deteriorated to such a degree, a Total Artificial Heart was the only option."
In 1996, Rathe received a heart transplant after a sudden onset of viral cardiomyopathy, a weakening of the heart muscle. After 17 years of life with his donor heart, his symptoms returned earlier this year.
"I used to run a frontend loader at a limestone quarry," said Rathe, who enjoys fishing and welding yard ornaments and toys. "I felt weak and couldn't breathe. When I got here, to the Med Center, they said I'd need a new heart."
Rathe was listed for a heart transplant in September 2012. According to his doctors, donor hearts have become available twice since then, but neither were a good match for Rathe, whose immune syst
|SOURCE SynCardia Systems, Inc.|
Copyright©2012 PR Newswire.
All rights reserved